MedTrace Logo

The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure

NCT01580553 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 268

Last updated 2012-04-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy and safety of L-carnitine injection in treatment of Chinese patients with heart failure.

A prospective, multicenter, randomized, double-blind, parallel, placebo-controlled clinical study was performed.

Treatment period: 7 days, follow-up: 1 month

Conditions

  • Heart Failure,

Interventions

DRUG

Levocarnitine Injection

Levocarnitine Injection:5ml:1g

DRUG

Levocarnitine placebo

L-Carnitine injection placebo (5ml:1g)

Sponsors & Collaborators

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01580553 on ClinicalTrials.gov